Global Negative Pressure Wound Therapy

Negative Pressure Wound Therapy Comprehensive Study by Type (Standalone NPWT Devices, Single use Disposable NPWT Devices, Portable NPWT Devices, NPWT Accessories (Canister)), Application (Hospital, Clinics, Home Care Settings) Players and Region - Global Market Outlook to 2030

Negative Pressure Wound Therapy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Negative pressure wound therapy (NPWT) is the therapy which heals acute and chronic wounds by applying vacuum through a sealed wound dressing. By this therapy the fluid and debris from the wound is drawn out by vacuum and the supply of blood in affected area to increase the healing rate. The demand for negative pressure wound theraphy is expected to rise in the forecasted period due to the increase in the incidence of cases of chronic diseases such as diabetes mellitus and obesity, increase in casualties caused by accidents & trauma and growth in geriatric population.This growth is primarily driven by Increasing Incidence of Diabetes Especially Among Obese Population .

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Diseases & Therapeutic Areas sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Acelity (United States), Cardinal Health (United States), ConvaTec (United Kingdom), DeRoyal (United States), Genadyne (United States), Lohmann & Rauscher (German), Medela (Switzerland), Smith & Nephew (United Kingdom), Mölnlycke Health Care AB (Sweden) and Talley Group (United Kingdom), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In November, 2023 – Medela, a global healthcare company known for being the most trusted breastfeeding brand in North America*, announced it will transition its wound care business into a separate global company.
In August 2023, Medela has announced plans to expand its negative pressure wound therapy (NPWT) portfolio with the introduction of the new Invia Integrated Dressing indicated for all types of wounds.

Regulatory Insights:
According to the International Diabetes Federation (IDF), the global adult diabetic population reached 425 million in 2017, and it is expected to reach around 629 million by 2045. A diabetic foot ulcer is a major complication of diabetes that could lead to leg amputation in severe cases if left untreated. NPWT devices play a significant role in the management of diabetic foot ulcers, which increases their demand across the globe.

Influencing Trend:
Rise in Usage of Simplified Single-Use Devices and Technological Advancements Such As Development Of Cost-Effective Disposable NPWT Devices

Market Growth Drivers:
Increasing Incidence of Diabetes Especially Among Obese Population, Government Initiative to Prevent SSIS and Rising Spending on Chronic and Surgical Wounds

Challenges:
Lack of Skilled Professionals.

Restraints:
Conventional Negative Pressure Wound Therapy Devices Are Capital-Intensive

Opportunities:
Growing Awareness Towards Management of Wounds

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Negative Pressure Wound Therapy Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Negative Pressure Wound Therapy Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Negative Pressure Wound Therapy players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Negative Pressure Wound Therapy Study Sheds Light on
— The Negative Pressure Wound Therapy Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Negative Pressure Wound Therapy industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Negative Pressure Wound Therapy industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Standalone NPWT Devices
  • Single use Disposable NPWT Devices
  • Portable NPWT Devices
  • NPWT Accessories (Canister)
By Application
  • Hospital
  • Clinics
  • Home Care Settings
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Diabetes Especially Among Obese Population
      • 3.2.2. Government Initiative to Prevent SSIS
      • 3.2.3. Rising Spending on Chronic and Surgical Wounds
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals.
    • 3.4. Market Trends
      • 3.4.1. Rise in Usage of Simplified Single-Use Devices
      • 3.4.2. Technological Advancements Such As Development Of Cost-Effective Disposable NPWT Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Negative Pressure Wound Therapy, by Type, Application and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Negative Pressure Wound Therapy (Value)
      • 5.2.1. Global Negative Pressure Wound Therapy by: Type (Value)
        • 5.2.1.1. Standalone NPWT Devices
        • 5.2.1.2. Single use Disposable NPWT Devices
        • 5.2.1.3. Portable NPWT Devices
        • 5.2.1.4. NPWT Accessories (Canister)
      • 5.2.2. Global Negative Pressure Wound Therapy by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Clinics
        • 5.2.2.3. Home Care Settings
      • 5.2.3. Global Negative Pressure Wound Therapy Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Negative Pressure Wound Therapy (Price)
      • 5.3.1. Global Negative Pressure Wound Therapy by: Type (Price)
  • 6. Negative Pressure Wound Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Acelity (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Cardinal Health (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. ConvaTec (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DeRoyal (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Genadyne (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lohmann & Rauscher (German)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medela (Switzerland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Smith & Nephew (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Mölnlycke Health Care AB (Sweden)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Talley Group (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Negative Pressure Wound Therapy Sale, by Type, Application and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Negative Pressure Wound Therapy (Value)
      • 7.2.1. Global Negative Pressure Wound Therapy by: Type (Value)
        • 7.2.1.1. Standalone NPWT Devices
        • 7.2.1.2. Single use Disposable NPWT Devices
        • 7.2.1.3. Portable NPWT Devices
        • 7.2.1.4. NPWT Accessories (Canister)
      • 7.2.2. Global Negative Pressure Wound Therapy by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Clinics
        • 7.2.2.3. Home Care Settings
      • 7.2.3. Global Negative Pressure Wound Therapy Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Negative Pressure Wound Therapy (Price)
      • 7.3.1. Global Negative Pressure Wound Therapy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Negative Pressure Wound Therapy: by Type(USD Million)
  • Table 2. Negative Pressure Wound Therapy Standalone NPWT Devices , by Region USD Million (2018-2023)
  • Table 3. Negative Pressure Wound Therapy Single use Disposable NPWT Devices , by Region USD Million (2018-2023)
  • Table 4. Negative Pressure Wound Therapy Portable NPWT Devices , by Region USD Million (2018-2023)
  • Table 5. Negative Pressure Wound Therapy NPWT Accessories (Canister) , by Region USD Million (2018-2023)
  • Table 6. Negative Pressure Wound Therapy: by Application(USD Million)
  • Table 7. Negative Pressure Wound Therapy Hospital , by Region USD Million (2018-2023)
  • Table 8. Negative Pressure Wound Therapy Clinics , by Region USD Million (2018-2023)
  • Table 9. Negative Pressure Wound Therapy Home Care Settings , by Region USD Million (2018-2023)
  • Table 10. South America Negative Pressure Wound Therapy, by Country USD Million (2018-2023)
  • Table 11. South America Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 12. South America Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 13. Brazil Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 14. Brazil Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 15. Argentina Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 16. Argentina Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 17. Rest of South America Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 18. Rest of South America Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 19. Asia Pacific Negative Pressure Wound Therapy, by Country USD Million (2018-2023)
  • Table 20. Asia Pacific Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 21. Asia Pacific Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 22. China Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 23. China Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 24. Japan Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 25. Japan Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 26. India Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 27. India Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 28. South Korea Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 29. South Korea Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 30. Taiwan Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 31. Taiwan Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 32. Australia Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 33. Australia Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 34. Rest of Asia-Pacific Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 36. Europe Negative Pressure Wound Therapy, by Country USD Million (2018-2023)
  • Table 37. Europe Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 38. Europe Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 39. Germany Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 40. Germany Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 41. France Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 42. France Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 43. Italy Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 44. Italy Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 45. United Kingdom Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 46. United Kingdom Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 47. Netherlands Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 48. Netherlands Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 49. Rest of Europe Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 50. Rest of Europe Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 51. MEA Negative Pressure Wound Therapy, by Country USD Million (2018-2023)
  • Table 52. MEA Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 53. MEA Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 54. Middle East Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 55. Middle East Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 56. Africa Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 57. Africa Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 58. North America Negative Pressure Wound Therapy, by Country USD Million (2018-2023)
  • Table 59. North America Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 60. North America Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 61. United States Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 62. United States Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 63. Canada Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 64. Canada Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 65. Mexico Negative Pressure Wound Therapy, by Type USD Million (2018-2023)
  • Table 66. Mexico Negative Pressure Wound Therapy, by Application USD Million (2018-2023)
  • Table 67. Negative Pressure Wound Therapy: by Type(USD/Units)
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Negative Pressure Wound Therapy: by Type(USD Million)
  • Table 79. Negative Pressure Wound Therapy Standalone NPWT Devices , by Region USD Million (2025-2030)
  • Table 80. Negative Pressure Wound Therapy Single use Disposable NPWT Devices , by Region USD Million (2025-2030)
  • Table 81. Negative Pressure Wound Therapy Portable NPWT Devices , by Region USD Million (2025-2030)
  • Table 82. Negative Pressure Wound Therapy NPWT Accessories (Canister) , by Region USD Million (2025-2030)
  • Table 83. Negative Pressure Wound Therapy: by Application(USD Million)
  • Table 84. Negative Pressure Wound Therapy Hospital , by Region USD Million (2025-2030)
  • Table 85. Negative Pressure Wound Therapy Clinics , by Region USD Million (2025-2030)
  • Table 86. Negative Pressure Wound Therapy Home Care Settings , by Region USD Million (2025-2030)
  • Table 87. South America Negative Pressure Wound Therapy, by Country USD Million (2025-2030)
  • Table 88. South America Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 89. South America Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 90. Brazil Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 91. Brazil Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 92. Argentina Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 93. Argentina Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 94. Rest of South America Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 95. Rest of South America Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 96. Asia Pacific Negative Pressure Wound Therapy, by Country USD Million (2025-2030)
  • Table 97. Asia Pacific Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 98. Asia Pacific Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 99. China Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 100. China Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 101. Japan Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 102. Japan Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 103. India Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 104. India Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 105. South Korea Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 106. South Korea Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 107. Taiwan Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 108. Taiwan Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 109. Australia Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 110. Australia Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 111. Rest of Asia-Pacific Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 112. Rest of Asia-Pacific Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 113. Europe Negative Pressure Wound Therapy, by Country USD Million (2025-2030)
  • Table 114. Europe Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 115. Europe Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 116. Germany Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 117. Germany Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 118. France Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 119. France Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 120. Italy Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 121. Italy Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 122. United Kingdom Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 123. United Kingdom Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 124. Netherlands Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 125. Netherlands Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 126. Rest of Europe Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 127. Rest of Europe Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 128. MEA Negative Pressure Wound Therapy, by Country USD Million (2025-2030)
  • Table 129. MEA Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 130. MEA Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 131. Middle East Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 132. Middle East Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 133. Africa Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 134. Africa Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 135. North America Negative Pressure Wound Therapy, by Country USD Million (2025-2030)
  • Table 136. North America Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 137. North America Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 138. United States Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 139. United States Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 140. Canada Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 141. Canada Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 142. Mexico Negative Pressure Wound Therapy, by Type USD Million (2025-2030)
  • Table 143. Mexico Negative Pressure Wound Therapy, by Application USD Million (2025-2030)
  • Table 144. Negative Pressure Wound Therapy: by Type(USD/Units)
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Negative Pressure Wound Therapy: by Type USD Million (2018-2023)
  • Figure 5. Global Negative Pressure Wound Therapy: by Application USD Million (2018-2023)
  • Figure 6. South America Negative Pressure Wound Therapy Share (%), by Country
  • Figure 7. Asia Pacific Negative Pressure Wound Therapy Share (%), by Country
  • Figure 8. Europe Negative Pressure Wound Therapy Share (%), by Country
  • Figure 9. MEA Negative Pressure Wound Therapy Share (%), by Country
  • Figure 10. North America Negative Pressure Wound Therapy Share (%), by Country
  • Figure 11. Global Negative Pressure Wound Therapy: by Type USD/Units (2018-2023)
  • Figure 12. Global Negative Pressure Wound Therapy share by Players 2023 (%)
  • Figure 13. Global Negative Pressure Wound Therapy share by Players (Top 3) 2023(%)
  • Figure 14. Global Negative Pressure Wound Therapy share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Acelity (United States) Revenue, Net Income and Gross profit
  • Figure 17. Acelity (United States) Revenue: by Geography 2023
  • Figure 18. Cardinal Health (United States) Revenue, Net Income and Gross profit
  • Figure 19. Cardinal Health (United States) Revenue: by Geography 2023
  • Figure 20. ConvaTec (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. ConvaTec (United Kingdom) Revenue: by Geography 2023
  • Figure 22. DeRoyal (United States) Revenue, Net Income and Gross profit
  • Figure 23. DeRoyal (United States) Revenue: by Geography 2023
  • Figure 24. Genadyne (United States) Revenue, Net Income and Gross profit
  • Figure 25. Genadyne (United States) Revenue: by Geography 2023
  • Figure 26. Lohmann & Rauscher (German) Revenue, Net Income and Gross profit
  • Figure 27. Lohmann & Rauscher (German) Revenue: by Geography 2023
  • Figure 28. Medela (Switzerland) Revenue, Net Income and Gross profit
  • Figure 29. Medela (Switzerland) Revenue: by Geography 2023
  • Figure 30. Smith & Nephew (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Smith & Nephew (United Kingdom) Revenue: by Geography 2023
  • Figure 32. Mölnlycke Health Care AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 33. Mölnlycke Health Care AB (Sweden) Revenue: by Geography 2023
  • Figure 34. Talley Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 35. Talley Group (United Kingdom) Revenue: by Geography 2023
  • Figure 36. Global Negative Pressure Wound Therapy: by Type USD Million (2025-2030)
  • Figure 37. Global Negative Pressure Wound Therapy: by Application USD Million (2025-2030)
  • Figure 38. South America Negative Pressure Wound Therapy Share (%), by Country
  • Figure 39. Asia Pacific Negative Pressure Wound Therapy Share (%), by Country
  • Figure 40. Europe Negative Pressure Wound Therapy Share (%), by Country
  • Figure 41. MEA Negative Pressure Wound Therapy Share (%), by Country
  • Figure 42. North America Negative Pressure Wound Therapy Share (%), by Country
  • Figure 43. Global Negative Pressure Wound Therapy: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Acelity (United States)
  • Cardinal Health (United States)
  • ConvaTec (United Kingdom)
  • DeRoyal (United States)
  • Genadyne (United States)
  • Lohmann & Rauscher (German)
  • Medela (Switzerland)
  • Smith & Nephew (United Kingdom)
  • Mölnlycke Health Care AB (Sweden)
  • Talley Group (United Kingdom)
Additional players considered in the study are as follows:
PAUL HARTMANN (Germany) , Coloplast (Denmark)
Select User Access Type

Key Highlights of Report


Jan 2024 229 Pages 73 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Negative Pressure Wound Therapy Quantitative research analysis
Global Negative Pressure Wound Therapy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2023; Base year: 2023; Forecast period: 2024 to 2030
Companies that are profiled in Global Negative Pressure Wound Therapy Market are Acelity (United States), Cardinal Health (United States), ConvaTec (United Kingdom), DeRoyal (United States), Genadyne (United States), Lohmann & Rauscher (German), Medela (Switzerland), Smith & Nephew (United Kingdom), Mölnlycke Health Care AB (Sweden) and Talley Group (United Kingdom) etc.
Hospital segment in Global market to hold robust market share owing to "Increasing Incidence of Diabetes Especially Among Obese Population ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Negative Pressure Wound Therapy market throughout the forecasted period.

Know More About Global Negative Pressure Wound Therapy Report?

Have a Query? Click Here

Other Related Reports

Chitosan Gel Comprehensive Study by Type (Industrial Grade, Pharmaceutical Grade, Others), Application (Surgical, Gynecological Diseases, Hemorrhoid Disease, Others), Distribution Channel (Hospital P...
$ 3450
Rosacea Treatment Comprehensive Study by Type (Erythematotelangiectatic Rosacea, Papulopustular Rosacea, Ocular Rosacea, Phymatous Rosacea), Drugs (Rhofade, Mirvaso, Oracea, Others), Route of Adminis...
$ 3750
Hadron Therapy Comprehensive Study by Type (Electron Beam, Neutron Beam, Alpha Particle Beam, Proton Beam, Carbon Ion Beam, Beta Particle Beam), Application (Treatment Applications, Research Applicat...
$ 3750
Adenomyosis Treatment Comprehensive Study by Type (Focal, Adenomyoma, Diffuse, Others), Application (Hospitals, Clinics, Ambulatory Surgical Centers, Others), Treatment (Anti-inflammatory Drugs (ibup...
$ 3750
Aneurysmal Subarachnoid Hemorrhage Comprehensive Study by Type (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Lumbar Puncture, Xanthochromia, Cerebral Angiography, Transcranial Dop...
$ 3650
Phenylketonuria Treatment Comprehensive Study by Type (Drugs (Kuvan, Pegvaliase and Others), Dietary Supplement), Application (Hospital Pharmacies, Drug Stores, Online Pharmacies, Pediatric Clinics),...
$ 3650